ADMA Biologics, Inc.
US ˙ NasdaqGM ˙ US0008991046

SecurityADMA / ADMA Biologics, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership5,005,481 shares
Latest Disclosed Value $ 45,101,264
Dimensional Fund Advisors Lp reports 3.51% increase in ownership of ADMA / ADMA Biologics, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 5,005,481 shares of ADMA Biologics, Inc. (US:ADMA) valued at $45,099,384 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 4,835,638 shares of ADMA Biologics, Inc.. This represents a change in shares of 3.51% during the quarter. The current value of the position is $39,893,684 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ADMA BIOLOGICS COM 000899104 5,005,481 169,843 3.51 45,101 -48.87 0.0020
2026-02-12 2025-12-31 13F ADMA BIOLOGICS COM 000899104 4,835,638 37,364 0.78 88,204 25.39 0.0185
2025-11-12 2025-09-30 13F ADMA BIOLOGICS COM 000899104 4,798,274 35,199 0.74 70,343 -18.90 0.0151
2025-08-12 2025-06-30 13F ADMA BIOLOGICS COM 000899104 4,763,075 -97,239 -2.00 86,735 -10.06 0.0201
2025-05-13 2025-03-31 13F ADMA BIOLOGICS COM 000899104 4,860,314 191,994 4.11 96,434 20.44 0.0240
2025-02-13 2024-12-31 13F ADMA BIOLOGICS COM 000899104 4,668,320 643,661 15.99 80,065 -0.48 0.0192
2024-11-07 2024-09-30 13F ADMA BIOLOGICS COM 000899104 4,024,659 866,699 27.44 80,449 127.88 0.0195
2024-08-09 2024-06-30 13F ADMA BIOLOGICS COM 000899104 3,157,960 -440,076 -12.23 35,305 48.67 0.0092
2024-05-10 2024-03-31 13F ADMA BIOLOGICS COM 000899104 3,598,036 106,975 3.06 23,747 50.50 0.0064
2024-02-07 2023-12-31 13F ADMA BIOLOGICS COM 000899104 3,491,061 561,243 19.16 15,780 50.45 0.0046
2023-11-09 2023-09-30 13F ADMA BIOLOGICS COM 000899104 2,929,818 1,651,433 129.18 10,489 122.34 0.0034
2023-08-09 2023-06-30 13F ADMA BIOLOGICS COM 000899104 1,278,385 1,222,854 2,202.11 4,717 2,477.60 0.0015
2023-05-12 2023-03-31 13F ADMA BIOLOGICS COM 000899104 55,531 0 0.00 184 0.0001
2023-02-09 2022-12-31 13F ADMA BIOLOGICS COM 000899104 55,531 -2,648 -4.55 0 -100.00 0.0001
2022-11-10 2022-09-30 13F ADMA BIOLOGICS COM 000899104 58,179 -5,783 -9.04 141 11.90 0.0001
2022-08-12 2022-06-30 13F ADMA BIOLOGICS COM 000899104 63,962 6,290 10.91 126 18.87 0.0000
2022-05-13 2022-03-31 13F ADMA BIOLOGICS COM 000899104 57,672 0 0.00 106 30.86 0.0000
2022-02-09 2021-12-31 13F ADMA BIOLOGICS COM 000899104 57,672 -45,546 -44.13 81 -30.77 0.0000
2021-11-12 2021-09-30 13F ADMA BIOLOGICS COM 000899104 103,218 -36,095 -25.91 117 -47.53 0.0000
2021-08-12 2021-06-30 13F ADMA BIOLOGICS COM 000899104 139,313 -12,400 -8.17 223 -16.48 0.0001
2021-05-14 2021-03-31 13F ADMA BIOLOGICS COM 000899104 151,713 151,713 8.90 267 19.73 0.0001
2021-02-25 2020-12-31 13F/A-2 ADMA BIOLOGICS COM 000899104 0 -11,840 -100.00 0 -100.00
2020-11-12 2020-09-30 13F ADMA BIOLOGICS COM 000899104 11,840 11,840 28 0.0000
2019-08-13 2019-06-30 13F ADMA BIOLOGICS COM 000899104 0 -14,127 -100.00 0 -100.00
2019-08-12 2019-03-31 13F/A-2 ADMA BIOLOGICS COM 000899104 14,127 0 0.00 54 58.82 0.0000
2019-05-10 2019-03-31 13F ADMA BIOLOGICS COM 000899104 14,127 0 54
2019-02-26 2018-12-31 13F/A-1 ADMA BIOLOGICS COM 000899104 14,127 14,127 34 0.0000
2019-02-13 2018-12-31 13F ADMA BIOLOGICS COM 000899104 14,127 34 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.